RightSmile, Inc. (RIGH) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerRightSmile, Inc. (RIGH) trades at $0.0001. Bud Genius, Inc. operates in the cannabis testing and profiling services sector. The company also provides cloud-based healthcare solutions, celebrity-endorsed product licensing, and data-driven rating systems for marijuana strains. Sector: Utilities.
Price as of · Last analyzed: Mar 17, 2026Analyst Coverage for RIGH: RIGH does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
RightSmile, Inc. (RIGH) Utility Operations & Dividend Profile
Bud Genius, Inc., operating in the utilities sector, focuses on cannabis testing and profiling services, alongside cloud-based healthcare solutions and celebrity-endorsed product licensing. The company also provides data-driven rating systems for marijuana strains, positioning itself as a multifaceted service provider in the cannabis industry.
What Is the Investment Thesis for RIGH?
Investing in Bud Genius, Inc. (RIGH) presents a high-risk, high-reward scenario. The company's negative P/E ratio of -0.00 and a significantly negative profit margin of -2013.3% indicate substantial losses. The company's beta of -22.83 suggests extreme volatility. Growth catalysts depend on successful market penetration of its cannabis testing services and healthcare solutions. The company's small size and limited resources pose challenges to scaling the business. The investment thesis hinges on the company's ability to achieve profitability and demonstrate sustainable revenue growth in the competitive cannabis and healthcare sectors.
Based on FMP financials and quantitative analysis
RIGH Key Highlights
Market capitalization of $0.00B indicates a micro-cap or nano-cap company with limited financial resources.
- Negative P/E ratio of -0.00 reflects the company's lack of profitability.
- Profit margin of -2013.3% highlights significant operational inefficiencies and substantial losses.
- Gross margin of 42.6% suggests potential in the core business activities if operational costs are managed effectively.
- Beta of -22.83 indicates extreme volatility and a negative correlation with the overall market.
Who Are RIGH's Competitors?
RIGH is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| ENO Entergy New Orleans, LLC | $19.71 | -1.45% | $169M | 50 5-pillar |
| GNE Genie Energy Ltd. | $16.11 | -1.95% | $430M | 94 5-pillar |
| EDN Empresa Distribuidora y Comercializadora Norte Sociedad Anónima | $20.83 | +4.46% | $872M | 55 5-pillar |
| CEPU Central Puerto S.A. | $12.43 | +6.42% | $1.86B | 99 5-pillar |
| FRMI Fermi, Inc. | $4.06 | +0.74% | $2.59B | 31 5-pillar |
| DTB DTE Energy Company 2020 Series | $14.81 | -0.20% | $3.08B | 40 5-pillar |
| DTG DTE Energy Company 2021 Series | $15.41 | -0.04% | $3.20B | 40 5-pillar |
| DTK DTE Energy Company 2025 Series | $20.97 | +0.48% | $4.32B | 66 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are RIGH's Key Strengths?
Diversified service offerings in cannabis and healthcare sectors.
- Proprietary data-driven rating systems.
- Celebrity endorsement network.
- Early mover advantage in niche markets.
What Are RIGH's Weaknesses?
Small size and limited resources.
- Negative profitability and high losses.
- High beta indicating extreme volatility.
- Limited market presence and brand recognition.
What Are the Key Risks for RIGH?
Financial-distress signal — its Altman Z-Score of -4.78 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Intense competition in the cannabis and healthcare sectors.
- Changing regulatory landscape for cannabis.
- Negative profitability and high losses.
- Limited financial resources and small size.
- Economic downturn affecting consumer spending.
What Are RIGH's Competitive Advantages?
- Proprietary data-driven rating systems for marijuana strains.
- Established relationships with celebrities for product endorsements.
- Early mover advantage in the cannabis testing and profiling market.
What Does RIGH Do?
Bud Genius, Inc., based in Carlsbad, California, operates within the utilities sector, providing cannabis testing and profiling services. The company also offers cloud-based healthcare solutions, enabling real-time health data uploads from smartphones to caregivers and naturopathy physicians. Furthermore, Bud Genius engages in celebrity-endorsed product licensing and retail merchandising services. A key aspect of their business involves providing data-driven rating systems for marijuana strains and cannabis products, aiming to offer consumers and businesses insights into product quality and characteristics. Founded to capitalize on the burgeoning cannabis market, Bud Genius has diversified its services to include healthcare solutions and licensing, attempting to leverage its brand and market presence across multiple sectors. The company's small size, with only 2 employees, suggests an early-stage operation or a business model heavily reliant on outsourcing and partnerships. Its focus on both cannabis-related services and healthcare solutions indicates an attempt to capture synergies between these markets, though the connection may not be immediately apparent to investors.
What Products and Services Does RIGH Offer?
- Provides cannabis testing and profiling services.
- Offers cloud-based healthcare solutions for real-time health data uploads.
- Engages in celebrity-endorsed product licensing.
- Provides retail merchandising services.
- Offers data-driven rating systems for marijuana strains.
- Provides data-driven rating systems for cannabis.
How Does RIGH Make Money?
- Generates revenue through cannabis testing and profiling services.
- Earns income from cloud-based healthcare solutions subscriptions.
- Receives royalties from celebrity-endorsed product licensing agreements.
What Industry Does RIGH Operate In?
Bud Genius, Inc. operates in the evolving cannabis industry, specifically within the testing and profiling services segment. This sector is characterized by increasing regulatory scrutiny and a growing demand for quality assurance. The company also participates in the cloud-based healthcare solutions market, which is experiencing rapid growth due to the increasing adoption of telehealth and remote patient monitoring. Competition includes established testing labs and healthcare technology providers. Bud Genius's success depends on its ability to differentiate its services and establish a strong market presence in these competitive landscapes.
Who Are RIGH's Key Customers?
- Cannabis cultivators and processors requiring testing services.
- Caregivers and naturopathy physicians utilizing cloud-based healthcare solutions.
- Retailers seeking celebrity-endorsed products.
- Consumers seeking data-driven ratings for marijuana strains.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Company Profile
RightSmile, Inc. operates in the Regulated Electric industry within the Utilities sector. It is headquartered in Carlsbad, US. The company is led by CEO Aaron Stanz. RIGH has traded publicly since 2009.
Key Financial Metrics
Return on equity for RightSmile, Inc. stands at 210.1%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.21 means current liabilities exceed short-term assets, a liquidity point worth watching.
Financial Health
RightSmile, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -4.78 places it in the distress zone, a signal of elevated financial risk.
RIGH Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
RIGH Latest News
-
Helus Pharma stock rating reiterated at Buy by H.C. Wainwright
All News · Aug 19, 2026
-
Europe should wish Marco Rubio a bright future
International homepage · Aug 19, 2026
-
Iran has Trump right where it wants him and suggests he seek ‘a dignified exit’
Fortune | FORTUNE · Aug 19, 2026
-
Remigration binds Maga to Europe’s far right
International homepage · Aug 19, 2026
RIGH Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for RIGH.
Price Targets
Wall Street price target analysis for RIGH.
RIGH MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for RIGH; grades run from A+ (80-100) to F (below 30).
Latest News
Helus Pharma stock rating reiterated at Buy by H.C. Wainwright
Europe should wish Marco Rubio a bright future
Iran has Trump right where it wants him and suggests he seek ‘a dignified exit’
Remigration binds Maga to Europe’s far right
Leadership: Aaron Stanz
CEO
Aaron Stanz serves as the CEO of Bud Genius, Inc., leading a small team of 2 employees. Information on his prior experience is limited, but his current role involves overseeing the company's operations in cannabis testing, healthcare solutions, and product licensing. His leadership is crucial for navigating the company through its early stages and establishing a sustainable business model.
Track Record: Due to the limited information available, Aaron Stanz's track record at Bud Genius, Inc. cannot be comprehensively assessed. The company's current financial state, characterized by negative profitability and high losses, suggests significant challenges. His strategic decisions and their impact on the company's performance require further evaluation based on future developments and financial results.
RIGH OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Bud Genius, Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited information available to investors, and trading activity can be sporadic and less transparent compared to listed exchanges like NYSE or NASDAQ. Investing in companies on the OTC Other tier carries a higher degree of risk due to the potential for limited liquidity and information.
- OTC Tier: OTC Other
- Limited financial disclosure and transparency.
- High risk of fraud or manipulation due to less stringent regulations.
- Significant price volatility and illiquidity.
- Potential for delisting or suspension of trading.
- Limited access to capital and funding opportunities.
- Verify the company's legal status and registration.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team's experience and track record.
- Understand the risks associated with investing in OTC securities.
- Consult with a qualified financial advisor.
- Check for any regulatory actions or legal proceedings.
- Verify the company's physical address and contact information.
- Check for independent audits of financial statements (if available).
- Assess the company's website and online presence.
- Look for verifiable customer testimonials or reviews.
- Review press releases and news articles about the company.
RIGH Utilities Stock FAQ
What do analysts say about RIGH stock?
As of March 17, 2026, there is no available analyst coverage for Bud Genius, Inc. (RIGH). The company's market capitalization of $0.00B and its OTC Other listing suggest limited institutional interest.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Limited information available on Bud Genius, Inc.
- Financial data may not be up-to-date.
- OTC market investments are highly speculative.